Imperatorin prevents cardiac hypertrophy and the transition to heart failure via NO-dependent mechanisms in mice

Fitoterapia

Volumn 83, Issue 1, 2012, Pages 60-66

  Zhang, Yan ^a,b   Cao, Yanjun ^a   Duan, Haijie ^a   Wang, Hongying ^a   He, Langchong ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b SHANDONG MENTAL HEALTH CENTER   (China)

Author keywords

Cardiac hypertrophy; Endothelial nitric oxide synthase (eNOS); Heart failure; Imperatorin; Nitric oxide (NO)

Indexed keywords

CARDIAC AGENT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ISOPRENALINE; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTOSALEN; PHENYLEPHRINE; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HEART FAILURE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; IN VITRO STUDY; IN VIVO STUDY; LUNG WEIGHT; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOMEGALY; CELLS, CULTURED; CYTOPLASMIC DYNEINS; GENE EXPRESSION REGULATION; HEART FAILURE; MALE; MICE; MYOCYTES, CARDIAC; NATRIURETIC PEPTIDE, BRAIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PSORALENS; RATS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

MUS; RATTUS;

EID: 83055176503     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2011.09.011     Document Type: Article

References (38)

1. Y. Ding, and N.D. Vaziri Calcium channel blockade enhances nitric oxide synthase expression by cultured endothelial cells Hypertension 32 1998 718 723 (Pubitemid 28480550)
2. M.C. Verhaar, M.L.H. Honing, T. van Dam, M. Zwart, H.A. Koomans, and J.J.P. Kastelein Nifedipine improves endothelial function in hypercholesterolemia, independently of an effect on blood pressure or plasma lipids Cardiovasc Res 42 1999 752 760 (Pubitemid 29298145)
3. H. Lenasi, K. Kohlstedt, B. Fichtlscherer, A. Mülsch, R. Busse, and I. Fleming Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495 Cardiovasc Res 59 2003 844 853 (Pubitemid 38366240)
4. 2+ blockers prevent myocardial remodeling induced by chronic NO inhibition in rats Hypertension 41 2003 963 967 (Pubitemid 36418473)
5. W. Linz, P. Wohlfart, B.A. Schölkens, T. Malinski, and G. Wiemer Interactions among ACE, kinins and NO Cardiovasc Res 43 1999 549 561 (Pubitemid 29369254)
6. M. Takemoto, K. Node, H. Nakagami, Y. Liao, M. Grimm, and Y. Takemoto Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy J Clin Invest 108 2001 1429 1437 (Pubitemid 33091980)
7. S. Hayashidani, H. Tsutsui, T. Shiomi, N. Suematsu, S. Kinugawa, and T. Ide Fluvastatin, a 3-Hydroxy-3-Methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and failure after experimental myocardial infarction Circulation 105 2002 868 873 (Pubitemid 34174929)
8. H. Ogita, K. Node, Y. Liao, F. Ishikura, S. Beppu, and H. Asanuma Raloxifene prevents cardiac hypertrophy and dysfunction in pressure-overloaded mice Hypertension 43 2004 237 242 (Pubitemid 38174181)
9. H.L. Wu, Y.H. Li, Y.H. Lin, R. Wang, Y.B. Li, and L. Tie Salvianolic acid B protects human endothelial cells from oxidative stress damage: a possible protective role of glucose-regulated protein 78 induction Cardiovasc Res 81 2009 148 158
10. Y. Wang, Y. Huang, K.S.L. Lam, Y. Li, W.T. Wong, and H. Ye Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase Cardiovasc Res 82 2009 484 492
11. Y. Ji, G.Q. Zeng, G.Q. Zeng, and D.X. Sun Antagonism of drugs on TNF-induced brain microvascular smooth muscle cell proliferation Acta Pharm Sin 29 1994 86 89
12. C.C. Wang, L.G. Chen, and L.L. Yang Inducible nitric oxide synthase inhibitor of the Chinese herb I. Saposhnikovia divaricata (Turcz.) Schischk Cancer Lett 145 1999 151 157
13. C.H. Tang, R.S. Yang, M.Y. Chien, C.C. Chen, and W.M. Fu Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts Eur J Pharmacol 579 2008 40 49
14. R. Sancho, N. Marquez, M. Gomez-Gonzalo, M.A. Calzado, G. Bettoni, and M.T. Coiras Imperatorin inhibits HIV-1 replication through an Sp1-dependent pathway J Biol Chem 279 2004 37349 37359 (Pubitemid 39195443)
15. 2+ influx and release Eur J Pharmacol 573 2007 170 175 (Pubitemid 47464207)
16. S. Fredj, J. Bescond, C. Louault, and D. Potreau Interactions between cardiac cells enhance cardiomyocyte hypertrophy and increase fibroblast proliferation J Cell Physiol 202 2005 891 899 (Pubitemid 40175867)
17. C. Louault, N. Benamer, J.F. Faivre, D. Potreau, and J. Bescond Implication of connexins 40 and 43 in functional coupling between mouse cardiac fibroblasts in primary culture Biochim Biophys Acta Biomembranes 1778 10 2008 2097 2104
18. C. Johns, I. Gavras, D.E. Handy, A. Salomao, and H. Gavras Models of experimental hypertension in mice Hypertention 28 1996 1064 1069 (Pubitemid 26415825)
19. P. Wiesel, L. Mazzolai, J. Nussberger, and T. Pedrazzini Two-kidney, one clip and one-kidney, one clip hypertension in mice Hypertention 29 1997 1025 1030 (Pubitemid 27152476)
20. M.A. Silver, R. Pick, C.G. Brilla, J.E. Jalil, J.S. Janicki, and K.T. Weber Reactive and reparative fibrillar collagen remodelling in the hypertrophied rat left ventricle: two experimental models of myocardial fibrosis Cardiovasc Res 24 9 1990 741 747 (Pubitemid 20289625)
21. S. Kurisu, R. Ozono, T. Oshima, M. Kambe, T. Ishida, and H. Sugino Cardiac angiotensin II Type 2 receptor activates the kinin/NO system and inhibits fibrosis Hypertention 41 2003 99 107 (Pubitemid 36056799)
22. N. Jeerooburkhan, L.C. Jones, S. Bujac, J.A. Cooper, G.J. Miller, and P. Vallance Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease Hypertention 38 2001 1054 1061 (Pubitemid 34252805)
23. L.C. Green, D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. Wishnok, and S.R. Tannenbaum Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids Anal Biochem 126 1 1982 131 138 (Pubitemid 13203451)
24. H. Hiyoshi, K. Yayama, M. Takano, and H. Okamoto Angiotensin type 2 receptor-mediated phosphorylation of eNOS in the aortas of mice with 2-kidney, 1-clip hypertension Hypertension 45 2005 967 973 (Pubitemid 40628945)
25. C. Arnaud, D. Godin-Ribuot, S. Bottari, A. Peinnequin, M. Joyeux, and P. Demenge iNOS is a mediator of the heat stress-induced preconditioning against myocardial infarction in vivo in the rat Cardiovasc Res 58 2003 118 125 (Pubitemid 36351628)
26. L. Tömäkangas, P. Vuorela, E. Saario, M. Leinonen, P. Saikku, and H. Vuorela In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model Biochem Pharmacol 70 2005 1222 1230 (Pubitemid 41317516)
27. A. Nakamura, G.V. Harrod, and K.E. Davies Activation of calcineurin and stress activated protein kinase/p38-mitogen activated protein kinase in hearts of utrophin-dystrophin knockout mice Neuromuscular Disord 11 2001 251 259 (Pubitemid 32288795)
28. B. Swynghedauw Molecular mechanisms of myocardial remodeling Physiol Rev 79 1999 215 262 (Pubitemid 29056953)
29. A.L. Moens, E. Takimoto, C.G. Tocchetti, K. Chakir, D. Bedja, and G. Cormaci Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy Circulation 117 2008 2626 2636
30. D. Tonduangu, L. Hittinger, B. Ghaleh, P. Le Corvoisier, L. Sambin, and S. Champagne Chronic infusion of bradykinin delays the progression of heart failure and preserves vascular endothelium-mediated vasodilation in conscious dogs Circulation 109 2004 114 119 (Pubitemid 38056031)
31. S.D. Katz, T. Khan, G.A. Zeballos, L. Mathew, P. Potharlanka, and M. Knecht Decreased activity of the l-arginine-nitric oxide metabolic pathway in patients with congestive heart failure Circulation 99 1999 2113 2117 (Pubitemid 29196794)
32. J.L. Balligand, R.A. Kelly, P.A. Marsden, T.W. Smith, and T. Michel Control of cardiac muscle cell function by an endogenous nitric oxide signaling system Proc Natl Acad Sci USA 90 1993 347 351 (Pubitemid 23010307)
33. P. Zhang, X. Xu, X. Hu, E.D. van Deel, G. Zhu, and Y. Chen Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure Circ Res 100 2007 1089 1098 (Pubitemid 46598934)
34. L.J. Dixon, D.R. Morgan, S.M. Hughes, L.T. McGrath, N.A. El-Sherbeeny, and R.D. Plumb Functional consequences of endothelial nitric oxide synthase uncoupling in congestive cardiac failure Circulation 107 2003 1725 1728 (Pubitemid 36418350)
35. S. Janssens, P. Pokreisz, L. Schoonjans, M. Pellens, P. Vermeersch, and M. Tjwa Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction Circ Res 94 2004 1256 1262 (Pubitemid 38656413)
36. J.J. Pan, P.P. Wu, H.W. Li, and W. Lu Preparation and pharmacokinetics of imperatorin sustained-release tablets J Xi'an Jiaotong Univ (Med Sci) 31 5 2010 584 587
37. H.E. Kleiner, S.V. Vulimiri, M.F. Starost, M.J. Reed, and J. DiGiovanni Oral administration of the citrus coumarin, isopimpinellin, blocks DNA adduct formation and skin tumor initiation by 7,12-dimethylbenz[a]anthracene in SENCAR mice Carcinogenesis 23 2002 1667 1675 (Pubitemid 35214952)
38. J. Zhang, G. Yang, Z. Hu, L. He, and H. Li LC-ESI-MS determination of imperatorin in rat plasma after oral administration and total furocoumarins of Radix Angelica dahuricae and its application to a pharmacokinetic study Chromatographia 69 2009 859 864